Improving lung cancer screening for Hispanic and vulnerable populations
Health Opportunities & Promoters of Equitable Screening for Lung Cancer (Hopes for Lung Cancer)
This study is all about helping Hispanic and other at-risk communities get better access to lung cancer screenings by understanding what makes it hard for them to get tested and finding ways to make it easier, so we can catch lung cancer early and improve survival rates together.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11041013 on NIH RePORTER |
What this research studies
This research focuses on increasing the uptake of lung cancer screening among Hispanic and other vulnerable populations who are at higher risk for lung cancer. The project aims to identify barriers and facilitators to documenting smoking status and promoting early detection of lung cancer. By developing tailored interventions, the research seeks to address disparities in lung cancer outcomes and improve survival rates. The approach includes community-based participatory research to engage affected populations in the process.
Who could benefit from this research
Good fit: Ideal candidates for this research are Hispanic current and former smokers, as well as individuals from other vulnerable populations at risk for lung cancer.
Not a fit: Patients who do not smoke or have never smoked may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved early detection of lung cancer and better survival rates for Hispanic and vulnerable populations.
How similar studies have performed: Previous research has shown success in using community-based approaches to improve cancer screening rates among underserved populations.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Flores, Efren — Massachusetts General Hospital
- Study coordinator: Flores, Efren
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.